Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06739031 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06739031 · ClinicalTrials.gov record · last posted 2026-08-21

Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors

Name: Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors — clinical trial record (NCT06739031)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorEnergenx Medical LTD.

Started2024-12-25

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The goal of this clinical trial is to verify the efficacy and safety of pulsed electric field (PEF) treatment of early-stage unreseectable non-small cell lung cancer(NSCLC) patients. The main questions it aims to answer are: * Safety of PEF treatment of early-stage unreseectable NSCLC patients. * Locoregional control of ablated lesions. * Survival and quality of life assessment of early-stage unreseectable NSCLC patients.

Protocol amendment history 1 change detected by DataLookout

2026-08-22

Recruitment opened

Trial Details

NCT Number	NCT06739031
Lead Sponsor	Energenx Medical LTD.
Conditions	NSCLC
Enrollment	126 participants
Start Date	2024-12-25
Primary Completion	2026-12-25 (estimated)
Study Completion	2027-08-25 (estimated)
Updated on ClinicalTrials.gov	2026-08-21